Abstract:Unlike organ transplants where an immunosuppressive environment is required, a successful pregnancy involves an extremely robust, dynamic, and responsive maternal immune system to maintain the development of the fetus. A specific set of hormones and cytokines are associated with a particular stage of pregnancy. Any disturbance that alters this fine balance could compromise the development and function of the placenta. Although there are numerous underlying causes of pregnancy-related complications, untimely activation of Toll-like receptors (TLR), primarily TLR4, by intrauterine microbes poses the greatest risk. TLR4 is an important Pattern Recognition Receptor (PRR), which activates both innate and adaptive immune cells. TLR4 activation by LPS or DAMPs leads to the production of pro-inflammatory cytokines via the MyD88 dependent or independent pathway. Immune cells modulate the materno–fetal interface by TLR4-mediated cytokine production, which changes at different stages of pregnancy. In most pregnancy disorders, such as PTB, PE, or placental malaria, the TLR4 expression is upregulated in immune cells or in maternal derived cells, leading to the aberrant production of pro-inflammatory cytokines at the materno–fetal interface. Lack of functional TLR4 in mice has reduced the pro-inflammatory responses, leading to an improved pregnancy, which further strengthens the fact that abnormal TLR4 activation creates a hostile environment for the developing fetus. A recent study proposed that endothelial and perivascular stromal cells should interact with each other in order to maintain a homeostatic balance during TLR4-mediated inflammation. It has been reported that depleting immune cells or supplying anti-inflammatory cytokines can prevent PTB, PE, or fetal death. Blocking TLR4 signaling or its downstream molecule by inhibitors or antagonists has proven to improve pregnancy-related complications to some extent in clinical and animal models. To date, there has been a lack of knowledge regarding whether TLR4 accessories such as CD14 and MD-2 are important in pregnancy and whether these accessory molecules could be promising drug targets for combinatorial treatment of various pregnancy disorders. This review mainly focuses on the activation of TLR4 during pregnancy, its immunomodulatory functions, and the upcoming advancement in this field regarding the improvement of pregnancy-related issues by various therapeutic approaches.

Toll-like Receptors and Spontaneous Abortion

Expression of TLR2 and TLR4 on Decidual and Villi in Unexplained Recurrent Spontaneous Abortion and Its Significance.

Toll-like Receptors in Female Reproductive Physiology and Pathology

Decreased Toll-like Receptor-2 Messenger Ribonucleic Acid and Increased Toll-like Receptor-4 in the Tubal Epithelium Next to the Infiltrated Trophoblasts During Tubal Pregnancy

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications

Expression and function of toll-like receptors at the maternal-fetal interface

Natural Killer Cell and Maternal-fetal Interface Immune Dysfunction in Recurrent Spontaneous Abortion

The Down-regulation of CD4~+CD25~+ T Cell Subpopulation and the Up-regulation of CD28~+ T Cell Population in Peripheral Blood are Involved in Human Spontaneous Abortion

The Role of Immune Cells in Recurrent Spontaneous Abortion

TLR signaling pathway and the effects of main immune cells and epigenetics factors on the diagnosis and treatment of infertility and sterility

The role of Th17 and Treg cells in normal pregnancy and unexplained recurrent spontaneous abortion (URSA): New insights into immune mechanisms

Altered Frequency and Function of Spleen CTLA-4+Tim-3+ T Cells Are Associated with Miscarriage†.

Role of maternal–fetal immune tolerance in the establishment and maintenance of pregnancy

Primary cilia abnormalities participate in the occurrence of spontaneous abortion through TGF‐β/SMAD2/3 signaling pathway

Insight Into TLR4-Mediated Immunomodulation in Normal Pregnancy and Related Disorders

The role of maternal–foetal interface inflammation mediated by NLRP3 inflammasome in the pathogenesis of recurrent spontaneous abortion

Tim-3 Protects Decidual Stromal Cells from Toll-Like Receptor-Mediated Apoptosis and Inflammatory Reactions and Promotes Th2 Bias at the Maternal-Fetal Interface.

Regulation of costimulatory signal in maternal-fetal immune tolerance.

O87 Increased Expression of Toll‐like Receptor 3 on Decidual Natural Killer Cells in Patients with Unexplained Recurrent Spontaneous Abortion

Expression of interleukin-2 and interleukin-4 at maternal-fetal interface in women with unexplained recurrent spontaneous abortion